Testosterone Products Testosterone is a male sex hormone produced in the testes and adrenal glands. It is responsible for development of male sexual characteristics, such as a deep voice and body hair. Testosterone levels spike during puberty and then gradually decline after age 30, causing low sex drive and erectile dysfunction in some men. Companies market several products to replace or boost testosterone, including patches, gels and injections. Men may also turn to less popular creams, nasal gels, capsules and tablets. Though administered differently, each testosterone product carries risks. It is important for men to understand these products and weigh the risks and benefits before beginning treatment. AndroGel is one of the most-used medical products to treat Low T. The blockbuster gel is prescribed as a testosterone-replacement drug, mostly to men whose bodies fail to produce sufficient amounts of the male hormone.raw Testosterone Sustanon 250 powder The drug was developed by Brussels-based pharmaceutical company Solvay Pharmaceuticals, and the U.S. Food and Drug Administration (FDA) approved it in 2000 for use by men diagnosed with hypogonadism, a drastic decline in testosterone level due to injury or disease. Abbott Laboratories, AbbVie’s parent company, bought the drug from Solvay in 2010 and soon began pumping millions into the drug’s marketing. Within two years, doctors sounded alerts about the drug’s dangerous side effects for older users — after many men gained prescriptions as a way to regain their youth or simply boost energy and sex drive. One of the biggest risks with AndroGel and other testosterone products is an increase in risk of heart attacks and strokes. The makers of AndroGel now face a growing number of lawsuits filed by men who suffered strokes, heart attacks and blood clots after using the drug. The lawsuits state Abbott and AbbVie failed to warn consumers about these risks. AbbVie spent nearly $80 million on aggressive marketing campaigns in 2012, and the gel generated over $1 billion in sales that year. AndroGel is the top-selling testosterone product in the U.S. AbbVie markets it in the U.S., while Abbott markets it overseas.